ACI’s Cancer Drug Discovery & Preclinical Development conference takes place in London, UK on 17th & 18th September 2014. This keystone event will focus on the early stages of cancer drug research, with interactive debate and detailed presentations on a wide range of topics. A diverse range of academic and industry experts will be there to ensure fair and balanced coverage of the latest developments in the field. All this takes place in a friendly environment designed to encourage networking between attendees
Key Topics
- Strategies for the identification of selective kinase inhibitors
- Overcoming mechanisms of drug resistance with new targeted anti-cancer therapies
- New therapeutic targets in epigenetics and newly described metabolic pathways
- DNA-targeted agents as part of a personalised approach to drug discovery
- Methods for establishing pharmacologically safe and effective dose in animal studies
- Engineering antibodies for targeted cancer therapy
- Preparing for exploratory development
Why Attend?
- Meet experts from the world of early-stage cancer drug development
- Analyse trends in drug discovery within both academia and industry
- Explore the road from discovery to development to final approval
- Learn about the latest computer-aided drug design technologies
- Hear case histories on drug discovery and preclinical development
Confirmed Speakers
Tao You, Systems Biologist, AstraZeneca
Sean Kitson, Investigator of Radiochemistry, Almac Group
Aliki Taylor, Observational Research Director, Amgen
Graham Smith, Team Leader, PET Radiochemistry, The Institute for Cancer Research
Steven Whittaker, Team Leader, Career Development Faculty, The Institute for Cancer Research
Angela Kukula, Director of Enterprise, The Institute for Cancer Research
Tim Hammonds, Deputy Director of Discovery, Cancer Research Technology
José Alfón, Vice President, Research and Development, Ability Pharmaceuticals
Who Should Attend?
Research Scientists, Team Leaders, Heads, Managers, Directors and other professionals working in the following areas related to oncology:
- Drug Discovery
- Preclinical Development
- Exploratory Development
- Medicinal Chemistry
- Computational chemistry
- Formulation
- Targeted therapeutics
- Translational Medicine
- Personalised medicine
- Genetics
- Regulatory Affairs
- Data Management
Sponsorship and Commercial Opportunities
Victor Kinlock
Tel: +44 (0)20 3141 0626
Email: vkinlock@acieu.net
Speaking Opportunities:
Ciaran Larkin
Tel: +44 (0)20 3141 0625
Email: clarkin@acieu.net
